Nurr1 overexpression exerts neuroprotective and anti-inflammatory roles via down-regulating CCL2 expression in both in vivo and in vitro Parkinson's disease models-Reference-Cited by-同舟云学术

Nurr1 overexpression exerts neuroprotective and anti-inflammatory roles via down-regulating CCL2 expression in both in vivo and in vitro Parkinson's disease models

Published:2017-01 Issue:4 Volume:482 Page:1312-1319
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Liu Wei,Gao Yang,Chang Na

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference26 articles.

1. Priorities in Parkinson's disease research;Meissner;Nat. Rev. Drug Discov.,2011

2. Contra-directional coupling of Nur77 and Nurr1 in neurodegeneration: a novel mechanism for memantine-induced anti-inflammation and anti-mitochondrial impairment;Wei;Mol. Neurobiol.,2016

3. Aetiopathogenesis of Parkinson's disease;Schapira;J. Neurol.,2011

4. Parkinson's disease and enhanced inflammatory response;Stojkovska;Exp. Biol. Med.,2015

5. Parkinson's disease in the nuclear age of neuroinflammation;Nolan;Trends Mol. Med.,2013

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural Optimization of Oxaprozin for Selective Inverse Nurr1 Agonism;Journal of Medicinal Chemistry;2024-07-31

2. Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growing;Communications Chemistry;2024-06-29

3. Angiotensin-converting enzyme inhibition prevents l-dopa-induced dyskinesia in a 6-ohda-induced mouse model of Parkinson's disease;European Journal of Pharmacology;2024-06

4. Defining a vitamin A5/X specific deficiency – vitamin A5/X as a critical dietary factor for mental health;International Journal for Vitamin and Nutrition Research;2024-06

5. STAT4 targets KISS1 to inhibit the oxidative damage, inflammation and neuronal apoptosis in experimental PD models by inactivating the MAPK pathway;Neurochemistry International;2024-05